ES2187300B1 - Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. - Google Patents
Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.Info
- Publication number
- ES2187300B1 ES2187300B1 ES200102517A ES200102517A ES2187300B1 ES 2187300 B1 ES2187300 B1 ES 2187300B1 ES 200102517 A ES200102517 A ES 200102517A ES 200102517 A ES200102517 A ES 200102517A ES 2187300 B1 ES2187300 B1 ES 2187300B1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- application
- medicines
- derivatives
- sulfonamids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
Derivados de sulfonamidas, su preparación y su aplicación como medicamentos. La presente invención se refiere a nuevos derivados de sulfonamidas, de fórmula general (I), así como a sus sales fisiológicamente aceptables, a los procedimientos para su preparación, a su aplicación como medicamentos en terapéutica humana y/o veterinaria y a las composiciones farmacéuticas que los contienen.
Priority Applications (49)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200102517A ES2187300B1 (es) | 2001-11-14 | 2001-11-14 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
UA20040604587A UA78252C2 (en) | 2001-11-14 | 2002-08-11 | Sulphonamide derivatives, methods of preparation thereof and application as pharmaceutical compositions |
ES02785439T ES2259387T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
SG200602676-9A SG146442A1 (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, their preparation and use as medicaments |
RU2004117850/04A RU2293082C2 (ru) | 2001-11-14 | 2002-11-08 | Производные сульфонамида, их получение и применение в качестве лекарственных средств |
SI200230302T SI1445252T1 (sl) | 2001-11-14 | 2002-11-08 | Derivati sulfonamida, njihova priprava in uporabale teh kot zdravilo |
NZ543393A NZ543393A (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
YU41104A RS41104A (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
EP05021228A EP1666462B1 (en) | 2001-11-14 | 2002-11-08 | N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
CNB028240804A CN1271052C (zh) | 2001-11-14 | 2002-11-08 | 磺酰胺衍生物、它们的制备和作为药物的用途 |
AT02785439T ATE319684T1 (de) | 2001-11-14 | 2002-11-08 | Sulfonamidderivate, deren herstellung und deren verwendung als medikamente |
NZ533136A NZ533136A (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
JP2003544012A JP4416505B2 (ja) | 2001-11-14 | 2002-11-08 | スルホンアミド誘導体類と、その製造方法及び医薬としての応用 |
ES05021228T ES2322068T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de n-(1h-indol-5-il)naftaleno-1-sulfonamida y compuestos relacionados como antagonistas del receptor de serotonina 5-ht6 para el tratamiento de trastornos del sistema nervioso central. |
DE60232029T DE60232029D1 (de) | 2001-11-14 | 2002-11-08 | N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems |
PT05021228T PT1666462E (pt) | 2001-11-14 | 2002-11-08 | Derivados de n-[1h-indol-5-il]-naftaleno-1-sulfonamida e compostos associados enquanto antagonistas do receptor 5- ht6 de serotonina para o tratamento de distúrbios do sistema nervoso central |
ARP020104303A AR037288A1 (es) | 2001-11-14 | 2002-11-08 | Compuestos derivados de sulfonamidas, procedimiento para la obtencion, composicion farmaceutica y uso para la elaboracion de un medicamento |
PL02373894A PL373894A1 (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
BR0214243-0A BR0214243A (pt) | 2001-11-14 | 2002-11-08 | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida |
DE60209779T DE60209779T2 (de) | 2001-11-14 | 2002-11-08 | Sulfonamidderivate, deren herstellung und deren verwendung als medikamente |
PT02785439T PT1445252E (pt) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamida, a sua preparacao e aplicacao co medicamentos |
KR10-2004-7007155A KR20040071685A (ko) | 2001-11-14 | 2002-11-08 | 설폰아마이드 유도체, 이들의 제조 방법 및 약물로서이들의 용도 |
CA2466965A CA2466965C (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, their preparation and use as medicaments |
EP02785439A EP1445252B1 (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
AT05021228T ATE428694T1 (de) | 2001-11-14 | 2002-11-08 | N-ä1h-indol-5-ylünaphthalin-1-sulphonamid- derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems |
HU0402317A HUP0402317A2 (hu) | 2001-11-14 | 2002-11-08 | Szulfonamidszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
DK02785439T DK1445252T3 (da) | 2001-11-14 | 2002-11-08 | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter |
PCT/ES2002/000518 WO2003042175A1 (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparación y su aplicación como medicamentos |
MXPA04004601A MXPA04004601A (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
IL16188502A IL161885A0 (en) | 2001-11-14 | 2002-11-08 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
TW091132989A TWI275585B (en) | 2001-11-14 | 2002-11-11 | Derivatives of sulphonamides, their preparation and use as medicaments |
US10/293,206 US7105515B2 (en) | 2001-11-14 | 2002-11-13 | Derivatives of sulphonamides, their preparation and use as medicaments |
ES200401084A ES2249129B2 (es) | 2001-11-14 | 2004-05-06 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
IS7263A IS7263A (is) | 2001-11-14 | 2004-05-13 | Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja |
EC2004005105A ECSP045105A (es) | 2001-11-14 | 2004-05-13 | Derivados de sulfonamidas, su preparacion y su aplicación como medicamentos |
HR20040429A HRP20040429B1 (en) | 2001-11-14 | 2004-05-14 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
ZA200404073A ZA200404073B (en) | 2001-11-14 | 2004-05-25 | Sulphonamide derivatives, the preperation thereof and the application of same as medicaments |
CO04048713A CO5590895A2 (es) | 2001-11-14 | 2004-05-26 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos |
MA27723A MA27093A1 (fr) | 2001-11-14 | 2004-06-07 | Derives de sulfonamides, leur preparation et leur application comme medicaments. |
NO20042478A NO20042478L (no) | 2001-11-14 | 2004-06-14 | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter |
US10/933,951 US7176200B2 (en) | 2001-11-14 | 2004-09-03 | Derivatives of sulphonamides, their preparation and use as medicaments |
HK05101004A HK1070053A1 (en) | 2001-11-14 | 2005-02-05 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
RU2005136355/04A RU2005136355A (ru) | 2001-11-14 | 2005-11-22 | Производные сульфонамида, их получение и применение в качестве лекарственных средств |
CY20061100709T CY1105362T1 (el) | 2001-11-14 | 2006-06-02 | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα |
US11/487,745 US7498328B2 (en) | 2001-11-14 | 2006-07-17 | Derivatives of sulphonamides, their preparation and use as medicaments |
US11/707,571 US7452881B2 (en) | 2001-11-14 | 2007-02-16 | Derivatives of sulphonamides, their preparation and use as medicaments |
IS8698A IS8698A (is) | 2001-11-14 | 2007-12-05 | Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja |
IL193234A IL193234A0 (en) | 2001-11-14 | 2008-08-04 | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
JP2009223711A JP5132649B2 (ja) | 2001-11-14 | 2009-09-29 | スルホンアミド誘導体類と、その製造方法及び医薬としての応用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200102517A ES2187300B1 (es) | 2001-11-14 | 2001-11-14 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2187300A1 ES2187300A1 (es) | 2003-05-16 |
ES2187300B1 true ES2187300B1 (es) | 2004-06-16 |
Family
ID=8499446
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200102517A Expired - Fee Related ES2187300B1 (es) | 2001-11-14 | 2001-11-14 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES05021228T Expired - Lifetime ES2322068T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de n-(1h-indol-5-il)naftaleno-1-sulfonamida y compuestos relacionados como antagonistas del receptor de serotonina 5-ht6 para el tratamiento de trastornos del sistema nervioso central. |
ES02785439T Expired - Lifetime ES2259387T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES200401084A Expired - Fee Related ES2249129B2 (es) | 2001-11-14 | 2004-05-06 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES05021228T Expired - Lifetime ES2322068T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de n-(1h-indol-5-il)naftaleno-1-sulfonamida y compuestos relacionados como antagonistas del receptor de serotonina 5-ht6 para el tratamiento de trastornos del sistema nervioso central. |
ES02785439T Expired - Lifetime ES2259387T3 (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES200401084A Expired - Fee Related ES2249129B2 (es) | 2001-11-14 | 2004-05-06 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
Country Status (34)
Country | Link |
---|---|
US (4) | US7105515B2 (es) |
EP (2) | EP1445252B1 (es) |
JP (2) | JP4416505B2 (es) |
KR (1) | KR20040071685A (es) |
CN (1) | CN1271052C (es) |
AR (1) | AR037288A1 (es) |
AT (2) | ATE319684T1 (es) |
BR (1) | BR0214243A (es) |
CA (1) | CA2466965C (es) |
CO (1) | CO5590895A2 (es) |
CY (1) | CY1105362T1 (es) |
DE (2) | DE60209779T2 (es) |
DK (1) | DK1445252T3 (es) |
EC (1) | ECSP045105A (es) |
ES (4) | ES2187300B1 (es) |
HK (1) | HK1070053A1 (es) |
HR (1) | HRP20040429B1 (es) |
HU (1) | HUP0402317A2 (es) |
IL (2) | IL161885A0 (es) |
IS (2) | IS7263A (es) |
MA (1) | MA27093A1 (es) |
MX (1) | MXPA04004601A (es) |
NO (1) | NO20042478L (es) |
NZ (2) | NZ543393A (es) |
PL (1) | PL373894A1 (es) |
PT (2) | PT1445252E (es) |
RS (1) | RS41104A (es) |
RU (2) | RU2293082C2 (es) |
SG (1) | SG146442A1 (es) |
SI (1) | SI1445252T1 (es) |
TW (1) | TWI275585B (es) |
UA (1) | UA78252C2 (es) |
WO (1) | WO2003042175A1 (es) |
ZA (1) | ZA200404073B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2313002T3 (es) * | 2003-05-09 | 2009-03-01 | Laboratorios Del Dr. Esteve, S.A. | Uso de derivados de sulfonamida para la fabricacion de un medicamento para la profilaxis y/o tratamiento de la ingestion de alimentos. |
ES2228268B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2222830B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 7-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2222829B1 (es) | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2228267B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2222832B1 (es) * | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2222827B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
SE0303480D0 (sv) * | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
DE602004021031D1 (de) * | 2004-01-02 | 2009-06-18 | Suven Life Sciences Ltd | Neue indenoä2,1-aüindene und isoindolä2,1-aüindol |
ES2246721B1 (es) * | 2004-08-10 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos. |
EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
DE602006018447D1 (de) * | 2005-04-13 | 2011-01-05 | Neuraxon Inc | Substituierte indolverbindungen mit nos-hemmender aktivität |
JP5026690B2 (ja) * | 2005-11-21 | 2012-09-12 | 株式会社ジャパンディスプレイイースト | 表示装置 |
DK1979314T3 (da) * | 2006-01-24 | 2013-02-04 | Lilly Co Eli | Indolsulfonamidmodulatorer af progesteronreceptorer |
EP1837332A1 (en) * | 2006-03-23 | 2007-09-26 | Laboratorios Del Dr. Esteve, S.A. | Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
JP5350219B2 (ja) * | 2006-04-13 | 2013-11-27 | ニューラクソン,インコーポレーテッド | Nos阻害活性を有する1,5および3,6−置換インドール化合物 |
EP1902733A1 (en) * | 2006-09-19 | 2008-03-26 | Laboratorios Del Dr. Esteve, S.A. | Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
EP1953153A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
EP1953141A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
EP2018861A1 (en) * | 2007-07-26 | 2009-01-28 | Laboratorios del Dr. Esteve S.A. | 5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain |
EP2020230B1 (en) * | 2007-08-01 | 2011-01-19 | Laboratorios del Dr. Esteve S.A. | Combination of at least two 5-HT6-Ligands |
EP2036888A1 (en) * | 2007-09-17 | 2009-03-18 | Laboratorios del Dr. Esteve S.A. | Naphthyl-substituted sulfonamides |
MX356032B (es) * | 2007-11-16 | 2018-04-11 | Neuraxon Inc | Compuestos indola y métodos para tratar el dolor visceral. |
WO2009062318A1 (en) * | 2007-11-16 | 2009-05-22 | Neuraxon, Inc. | 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
CA2705422A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
EP2116547A1 (en) * | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands |
EP2116546A1 (en) * | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands |
BR112016001781A2 (pt) * | 2013-08-02 | 2017-08-01 | Pfizer | inibidores de rorc2 e métodos de uso dos mesmos |
MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472870A (en) | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
EA001113B1 (ru) * | 1995-03-20 | 2000-10-30 | Эли Лилли Энд Компани | 5-замещенные-3-(1,2,3,6-тетрагидропиридин-4-ил)- и 3-(пиперидин-4-ил)-1н-индолы и их фармацевтически приемлемые соли и сольваты, фармацевтическая композиция на их основе, способ активации рецепторов 5-нт1 и способ ингибирования нейронной белковой транссудации |
US5962473A (en) * | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
EP0875513A1 (en) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituted heteroaromatic 5-HT 1F agonists |
US6380201B1 (en) * | 1997-08-05 | 2002-04-30 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
-
2001
- 2001-11-14 ES ES200102517A patent/ES2187300B1/es not_active Expired - Fee Related
-
2002
- 2002-08-11 UA UA20040604587A patent/UA78252C2/uk unknown
- 2002-11-08 HU HU0402317A patent/HUP0402317A2/hu unknown
- 2002-11-08 AR ARP020104303A patent/AR037288A1/es not_active Application Discontinuation
- 2002-11-08 PT PT02785439T patent/PT1445252E/pt unknown
- 2002-11-08 SI SI200230302T patent/SI1445252T1/sl unknown
- 2002-11-08 CN CNB028240804A patent/CN1271052C/zh not_active Expired - Fee Related
- 2002-11-08 NZ NZ543393A patent/NZ543393A/en unknown
- 2002-11-08 ES ES05021228T patent/ES2322068T3/es not_active Expired - Lifetime
- 2002-11-08 AT AT02785439T patent/ATE319684T1/de active
- 2002-11-08 ES ES02785439T patent/ES2259387T3/es not_active Expired - Lifetime
- 2002-11-08 BR BR0214243-0A patent/BR0214243A/pt not_active IP Right Cessation
- 2002-11-08 CA CA2466965A patent/CA2466965C/en not_active Expired - Fee Related
- 2002-11-08 EP EP02785439A patent/EP1445252B1/en not_active Expired - Lifetime
- 2002-11-08 WO PCT/ES2002/000518 patent/WO2003042175A1/es active Application Filing
- 2002-11-08 RS YU41104A patent/RS41104A/sr unknown
- 2002-11-08 RU RU2004117850/04A patent/RU2293082C2/ru not_active IP Right Cessation
- 2002-11-08 KR KR10-2004-7007155A patent/KR20040071685A/ko not_active Application Discontinuation
- 2002-11-08 DE DE60209779T patent/DE60209779T2/de not_active Expired - Lifetime
- 2002-11-08 PT PT05021228T patent/PT1666462E/pt unknown
- 2002-11-08 DK DK02785439T patent/DK1445252T3/da active
- 2002-11-08 JP JP2003544012A patent/JP4416505B2/ja not_active Expired - Fee Related
- 2002-11-08 MX MXPA04004601A patent/MXPA04004601A/es active IP Right Grant
- 2002-11-08 IL IL16188502A patent/IL161885A0/xx unknown
- 2002-11-08 EP EP05021228A patent/EP1666462B1/en not_active Expired - Lifetime
- 2002-11-08 PL PL02373894A patent/PL373894A1/xx not_active Application Discontinuation
- 2002-11-08 DE DE60232029T patent/DE60232029D1/de not_active Expired - Lifetime
- 2002-11-08 NZ NZ533136A patent/NZ533136A/en unknown
- 2002-11-08 SG SG200602676-9A patent/SG146442A1/en unknown
- 2002-11-08 AT AT05021228T patent/ATE428694T1/de active
- 2002-11-11 TW TW091132989A patent/TWI275585B/zh not_active IP Right Cessation
- 2002-11-13 US US10/293,206 patent/US7105515B2/en not_active Expired - Fee Related
-
2004
- 2004-05-06 ES ES200401084A patent/ES2249129B2/es not_active Expired - Fee Related
- 2004-05-13 EC EC2004005105A patent/ECSP045105A/es unknown
- 2004-05-13 IS IS7263A patent/IS7263A/is unknown
- 2004-05-14 HR HR20040429A patent/HRP20040429B1/xx not_active IP Right Cessation
- 2004-05-25 ZA ZA200404073A patent/ZA200404073B/en unknown
- 2004-05-26 CO CO04048713A patent/CO5590895A2/es not_active Application Discontinuation
- 2004-06-07 MA MA27723A patent/MA27093A1/fr unknown
- 2004-06-14 NO NO20042478A patent/NO20042478L/no not_active Application Discontinuation
- 2004-09-03 US US10/933,951 patent/US7176200B2/en not_active Expired - Fee Related
-
2005
- 2005-02-05 HK HK05101004A patent/HK1070053A1/xx not_active IP Right Cessation
- 2005-11-22 RU RU2005136355/04A patent/RU2005136355A/ru not_active Application Discontinuation
-
2006
- 2006-06-02 CY CY20061100709T patent/CY1105362T1/el unknown
- 2006-07-17 US US11/487,745 patent/US7498328B2/en not_active Expired - Fee Related
-
2007
- 2007-02-16 US US11/707,571 patent/US7452881B2/en not_active Expired - Fee Related
- 2007-12-05 IS IS8698A patent/IS8698A/is unknown
-
2008
- 2008-08-04 IL IL193234A patent/IL193234A0/en unknown
-
2009
- 2009-09-29 JP JP2009223711A patent/JP5132649B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2187300B1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
PA8592201A1 (es) | Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen estos compuestos y sus usos | |
PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
UY28732A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparación y su uso como medicamentos. | |
UY27891A1 (es) | Nuevos derivados de glicosido de tiofeno, procedimientos para la preparación de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos. | |
PA8570901A1 (es) | Derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso | |
ECSP066325A (es) | Derivados de 5-indolilsulfonamidas, su preparación y su uso como moduladores de 5-ht-6 | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY27516A1 (es) | Bencimidazoles | |
CU23105A3 (es) | DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS | |
BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
UY30681A1 (es) | Compuestos de piridinamida que contienen carboxi, sales farmacéuticamente aceptables, procedimientos para la preparacion de los mismos, composiciones que los contienen y sus usos. | |
ECSP066330A (es) | Derivados de 1-sulfonilindol, su preparación y su uso como lingados de 5-ht-6 | |
UY28510A1 (es) | Compuestos quimicos | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
CR7069A (es) | Derivados de pirazol para el tratamiento de vih | |
CU22995A3 (es) | Derivados de pirazolinas, su preparación y su aplicación como medicamentos | |
BRPI0517792A (pt) | macrolonas - quinolonas amino-substituìdas | |
HN2003000185A (es) | Difenilazetidinonas sustituidas en grupo acido, procedimiemto para su preparacion, medicamentos que comprenden estso compuestos y su uso. | |
UY30856A1 (es) | Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk | |
NO20060155L (no) | Indol-4-sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer | |
CU23415B7 (es) | Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos | |
CR9469A (es) | Derivados de urea, metodos para su fabricacion y usos para los mismos | |
UY27851A1 (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
UY28547A1 (es) | Derivados de disulfuro, sulfuro, sulfóxido y sulfona de azúcares cíclicos y sus usos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20030516 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2187300B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20190521 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20190604 |